QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Koehler, S. E. Articles by Ladner, R. D. Search for Related Content PubMed PubMed Citation Articles by Koehler, S. E. Articles by Ladner, R. D. Pubmed/NCBI databases Substance via MeSH

Small Interfering RNA-Mediated Suppression of dUTPase Sensitizes Cancer Cell Lines to Thymidylate Synthase Inhibition

Department of Molecular Biology, the University of Medicine and Dentistry of New Jersey, School of Osteopathic Medicine, Stratford, New Jersey

Uracil misincorporation into DNA and its associated misrepair have been implicated as contributing components of cytotoxicity resulting from treatment with thymidylate synthase inhibitors. dUTPase, which eliminates dUTP from the DNA biosynthetic pathway, opposes uracil misincorporation; therefore, elevation of this enzyme in cancer cells may contribute to drug resistance. To validate the potential of dUTPase as a target for drug development, we used small interfering RNA directed against this enzyme and determined the effects of decreasing levels of dUTPase on sensitivity to the thymidylate synthase (TS) inhibitor fluorodeoxyuridine (FUdR) in human cancer cell lines. Suppression of dUTPase in SW620 and MCF-7 cells resulted in a significant enhancement in dUTP pool expansion after TS inhibition. This shift in nucleotide pool levels was accompanied by a significant decrease in the FUdR IC₅₀^72h (75-fold for SW620 cells and 6-fold for MCF-7 cells), a decline in clonogenic survival, and enhanced DNA double strand break formation. In contrast, depletion of dUTPase in HT29 cells did not substantially affect chemosensitivity or the amount of DNA damage incurred despite a 3-fold increase in dUTP pool expansion. This observation implies that the cytotoxic impact of uracil misincorporation may reach a saturation point in HT29 cells and that a further increase in dUTP levels has no additive effect. Together, these results suggest that uracil misincorporation is a potent determinant of cytotoxicity to TS inhibition and indicate that partial inhibition of dUTPase is a viable therapeutic approach to enhance the efficacy of broadly used chemotherapeutic agents that inhibit TS.

Received February 19, 2004; accepted June 7, 2004.

Address correspondence to: Robert D. Ladner, Ph.D., Department of Molecular Biology, The University of Medicine and Dentistry of New Jersey, School of Osteopathic Medicine, 2 Medical Center Drive, Stratford, NJ 08084. E-mail: ladner{at}umdnj.edu

This article has been cited by other articles:

				R. M. Wanner, D. Castor, C. Guthlein, E. C. Bottger, B. Springer, and J. Jiricny The Uracil DNA Glycosylase UdgB of Mycobacterium smegmatis Protects the Organism from the Mutagenic Effects of Cytosine and Adenine Deamination J. Bacteriol., October 15, 2009; 191(20): 6312 - 6319. [Abstract] [Full Text] [PDF]

				F. M. Muggia, G. J. Peters, and J. R. Landolph Jr. XIII International Charles Heidelberger Symposium and 50 Years of Fluoropyrimidines in Cancer Therapy Held on September 6 to 8, 2007 at New York University Cancer Institute, Smilow Conference Center Mol. Cancer Ther., May 1, 2009; 8(5): 992 - 999. [Abstract] [Full Text] [PDF]

				P. M. Wilson, W. Fazzone, M. J. LaBonte, H.-J. Lenz, and R. D. Ladner Regulation of human dUTPase gene expression and p53-mediated transcriptional repression in response to oxaliplatin-induced DNA damage Nucleic Acids Res., January 1, 2009; 37(1): 78 - 95. [Abstract] [Full Text] [PDF]

				P. M. Wilson, W. Fazzone, M. J. LaBonte, J. Deng, N. Neamati, and R. D. Ladner Novel opportunities for thymidylate metabolism as a therapeutic target Mol. Cancer Ther., September 1, 2008; 7(9): 3029 - 3037. [Abstract] [Full Text] [PDF]

				Q. An, P. Robins, T. Lindahl, and D. E. Barnes 5-Fluorouracil Incorporated into DNA Is Excised by the Smug1 DNA Glycosylase to Reduce Drug Cytotoxicity Cancer Res., February 1, 2007; 67(3): 940 - 945. [Abstract] [Full Text] [PDF]

				J. A. Fischer, S. Muller-Weeks, and S. J. Caradonna Fluorodeoxyuridine Modulates Cellular Expression of the DNA Base Excision Repair Enzyme Uracil-DNA Glycosylase. Cancer Res., September 1, 2006; 66(17): 8829 - 8837. [Abstract] [Full Text] [PDF]

				K. Dornfeld and M. Johnson AP endonuclease deficiency results in extreme sensitivity to thymidine deprivation Nucleic Acids Res., November 27, 2005; 33(20): 6644 - 6653. [Abstract] [Full Text] [PDF]